National Cancer Institute
Found 768 results for your search:
Total relevant funding to Brain for this search:
$194,189,633
Fiscal Year FY 2016
Cancer Type [Brain]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 768 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy 1R01CA208526-01 $484,047 $484,047 CUCINOTTA, FRANCIS UNIVERSITY OF NEVADA LAS VEGAS
2
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto 5R01CA190121-03 $332,000 $332,000 VERHAAK, ROELAND UNIVERSITY OF TX MD ANDERSON CAN CTR
3
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation 1R01CA208535-01 $536,390 $536,390 GROSSHANS, DAVID UNIVERSITY OF TX MD ANDERSON CAN CTR
4
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu 5R01CA185039-03 $373,436 $373,436 JAN, LILY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
5
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors 5R01CA194470-02 $464,569 $153,308 JANES, KEVIN UNIVERSITY OF VIRGINIA
6
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data 5R01CA185486-03 $517,690 $258,845 RABADAN, RAUL COLUMBIA UNIVERSITY HEALTH SCIENCES
7
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw 7R01CA185137-03 $918,872 $918,872 CHAREST, ALAIN BETH ISRAEL DEACONESS MEDICAL CENTER
8
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction 5R01CA185402-03 $322,828 $322,828 LI, XIONAN BAYLOR COLLEGE OF MEDICINE
9
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma 5R01CA184320-03 $738,276 $738,276 SARKARIA, JANN MAYO CLINIC ROCHESTER
10
5-hydroxymethylcytosine in human cancer 5R01CA160965-05 $394,250 $197,125 PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE
11
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation 5K01CA181292-04 $119,534 $29,884 CASTILLO, RICHARD UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
12
A causal role for asymmetric cell division defects in glioma initiation 4R01CA164746-05 $320,588 $320,588 PETRITSCH, CLAUDIA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
13
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy 1R01CA203873-01 $379,150 $379,150 FARRAR, CHRISTIAN MASSACHUSETTS GENERAL HOSPITAL
14
A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy 1F31CA210535-01 $31,686 $31,686 RICCIONE, KATHERINE DUKE UNIVERSITY
15
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers 1R33CA202900-01 $418,128 $418,128 BREUNIG, JOSHUA CEDARS-SINAI MEDICAL CENTER
16
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling 1R01CA181231-01A1 $362,569 $181,285 REITER, JEREMY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
17
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3 5F31CA200273-02 $43,576 $43,576 VENKATESH, HUMSA STANFORD UNIVERSITY
18
A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep 5F31CA186668-03 $34,293 $34,293 VILLA, GENARO LUDWIG INSTITUTE FOR CANCER RES LTD
19
A novel pathway to clear cells of misfolded proteins ZIA BC 011628 $189,172 $141,879 Walters, Kylie CCR (NCI)
20
A novel strategy to overcome resistance in Temozolomide-Refractory Glioblastomas 5R21CA195149-02 $199,553 $199,553 HERGENROTHER, PAUL UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
21
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS 5R44CA183287-03 $435,490 $435,490 BRAMHILL, DAVID ENDURX PHARMACEUTICALS, INC.
22
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas 5R01CA198076-02 $618,770 $618,770 PORTNOW, JANA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
23
A Predictive Prognostic Model for Glioblastoma Multiforme 4R01CA157553-05 $439,111 $439,111 BUI, ALEX UNIVERSITY OF CALIFORNIA LOS ANGELES
24
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors 4K07CA178100-04 $130,495 $130,495 HOCKING, MATTHEW CHILDREN'S HOSP OF PHILADELPHIA
25
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,229,987 $61,499 Sinha, Rashmi DCEG (NCI)
26
Abramson Cancer Center Support Grant 2P30CA016520-40 $7,975,543 $159,511 DANG, CHI UNIVERSITY OF PENNSYLVANIA
27
Abramson Cancer Center Support Grant 3P30CA016520-40S1 $31,250 $625 DANG, CHI UNIVERSITY OF PENNSYLVANIA
28
Abramson Cancer Center Support Grant 3P30CA016520-40S2 $499,967 $9,999 DANG, CHI UNIVERSITY OF PENNSYLVANIA
29
Abramson Cancer Center Support Grant 3P30CA016520-40S3 $200,000 $4,000 DANG, CHI UNIVERSITY OF PENNSYLVANIA
30
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging 4R01CA166171-04 $432,600 $432,600 ZHOU, JINYUAN JOHNS HOPKINS UNIVERSITY
31
Adaptive resistance to HIF1a inhibition in hypoxia 1R01CA207377-01 $352,242 $116,240 QIAN, ZHENG DAVID OREGON HEALTH & SCIENCE UNIVERSITY
32
Adult Brain Tumor Consortium (ABTC) 3UM1CA137443-07S1 $250,000 $250,000 GROSSMAN, STUART JOHNS HOPKINS UNIVERSITY
33
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology 1R33CA206949-01 $501,426 $250,713 SPICER, TIMOTHY SCRIPPS FLORIDA
34
AIDS Malignancy Consortium (AMC) 5UM1CA121947-10 $21,619,997 $5,404,999 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
35
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S1 $1,595,651 $39,891 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
36
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S2 $550,000 $13,750 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
37
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S3 $750,000 $18,750 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
38
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-03 $9,068,022 $226,701 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
39
An investigation of Radial Glia as the source of Ependymoma Stem Cells 5R01CA129541-11 $199,044 $99,522 GILBERTSON, RICHARD UNIVERSITY OF CAMBRIDGE
40
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer 4R01CA169345-04 $322,663 $322,663 WALDMAN, TODD GEORGETOWN UNIVERSITY
41
Anatomic Pathology Residency Program ZIE BC 011384 $1,014,935 $91,344 Barr, Frederic CCR (NCI)
42
Angiogenesis-targeting therapy for glioblastoma 3R01CA129371-09S1 $173,281 $173,281 BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL
43
Angiogenesis-targeting therapy for glioblastoma 4R01CA129371-09 $592,913 $592,913 BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL
44
ANTI-PDZ DOMAIN ANTIBODIES ENHANCE THE EFFICACY OF RADIOTHERAPY 1R43CA210687-01 $216,853 $71,561 ROTI ROTI, JOE MEDICAL GUIDANCE SYSTEMS, LLC
45
Anticancer Drug Pharmacology in Very Young Children 4R01CA154619-05 $433,475 $433,475 STEWART, CLINTON ST. JUDE CHILDREN'S RESEARCH HOSPITAL
46
Apoptotic Proteins as Molecular Modulators of Stem Cell Fate 5R00CA178190-04 $249,000 $249,000 GAMA, VIVIAN VANDERBILT UNIVERSITY
47
ATP-Dependent Chromatin Remodeling in Human Malignancy 4R01CA163915-05 $328,914 $82,229 CRABTREE, GERALD STANFORD UNIVERSITY
48
ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development 5F30CA192832-02 $33,814 $33,814 LANG, YUN LONG UNIV OF NORTH CAROLINA CHAPEL HILL
49
Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma 1R21CA202403-01A1 $176,131 $176,131 BURMA, SANDEEP UT SOUTHWESTERN MEDICAL CENTER
50
Autophagy as a microenvironmental regulator of tumorigenesis and resistance 5R01CA188404-03 $422,163 $422,163 DEBNATH, JAYANTA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Total relevant funding to Brain for this search: $194,189,633
Showing 1 - 50 of 768 results
Go to top